Association of biomarkers in pre-invasive and invasive cervical carcinoma (original) (raw)

Analysis of HPV16, 18, 31, and 35 DNA in pre-invasive and invasive lesions of the uterine cervix

Journal of Clinical Pathology, 1997

View PDFchevron_right

Study of the proliferative activity of various premalignant & malignant cervical lesions with a correlation to HPV status

2016

View PDFchevron_right

High risk HPV and p53 protein expression in cervical intraepithelial neoplasia

Liliana Andrade

International Journal of Gynecology & Obstetrics, 2000

View PDFchevron_right

Current scenario of biomarkers in cervical cancer and oncogenesis by HPV

Danielle Traesel

Jornal Brasileiro de Doenças Sexualmente Transmissíveis, 2019

View PDFchevron_right

The Association of Molecular Biomarkers in the Diagnosis of Cervical Pre-Cancer and Cancer and Risk Factors in Senegalese

Dominique Diouf

Asian Pacific Journal of Cancer Prevention

View PDFchevron_right

Human papillomavirus (HPV) DNA is not detected in the peripheral blood cells of patients with cervical carcinoma

Sexually Transmitted Infections, 1994

View PDFchevron_right

Human papillomavirus DNA in cervical carcinoma—correlation with clinical data and influence on prognosis

International Journal of Cancer, 1994

View PDFchevron_right

Clinical significance of serum human papillomavirus DNA in cervical carcinoma

Obstetrics & Gynecology, 2003

View PDFchevron_right

Human papillomavirus DNA integration and messenger RNA transcription in cervical low- and high-risk squamous intraepithelial lesions in Austrian women

Gernot Hudelist

International Journal of Gynecological Cancer, 2008

View PDFchevron_right

Low-Cost Molecular Biomarker HPV-16/18 E6 Oncoprotein Expression in Cervical Intraepithelial Neoplasia (CIN) and Cervical Cancer with Its Relation with Severity of Neoplastic State

Indian Journal of Gynecologic Oncology, 2020

View PDFchevron_right

High risk HPV in situ hybridization, p16 INK 4A, and survivin expressions in cervical carcinomas and intraepithelial neoplasms: evaluation of prognostic factors

European journal of gynaecological oncology

View PDFchevron_right

Relation between high risk HPV E6 and p53 proteins expression in cervical carcinoma and their premalignant lesions

View PDFchevron_right

Aetiology, pathogenesis, and pathology of cervical neoplasia

patience selelo

View PDFchevron_right

Characterization of molecular markers indicative of cervical cancer progression

PROTEOMICS - Clinical Applications, 2009

View PDFchevron_right

Risk Categorization with Different Grades of Cervical Pre-Neoplastic Lesions - High Risk HPV Associations and Expression of p53 and RARβ

Asian Pacific Journal of Cancer Prevention, 2019

View PDFchevron_right

Molecular Markers for Early Detection of Cervical Neoplasia

Disease Markers, 2004

View PDFchevron_right

Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study

American journal of obstetrics and gynecology, 2017

View PDFchevron_right

Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix

Giovanni Capelli

Journal of clinical …, 2009

View PDFchevron_right

A clinicopathological study of neoplastic and preneoplastic lesions of cervix along with HPV genotyping in biopsy proven preneoplastic lesions

IP Innovative Publication Pvt. Ltd.

2016

View PDFchevron_right

Detection of HPV-induced Cervical (Pre) Neoplastic Lesions

Applied Immunohistochemistry & Molecular Morphology, 2008

View PDFchevron_right

Determination of malignant potential of cervical intraepithelial neoplasia

Tumor Biology, 2015

View PDFchevron_right

Expression Analysis of p53, Ki-67 and bcl-2 in Pre-Malignant Lesions of the Cervix

Alessandra Godoy

Open Journal of Obstetrics and Gynecology, 2014

View PDFchevron_right

Expression of E6, p53 and p21 proteins and physical state of HPV16 in cervical cytologies with and without low grade lesions

International journal of clinical and experimental medicine, 2014

View PDFchevron_right

Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2002

View PDFchevron_right

Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade

Gernot Hudelist

Gynecologic Oncology, 2004

View PDFchevron_right

Functional biomarkers in cervical precancer: An overview

Radhika Srinivasan

Diagnostic Cytopathology, 2009

View PDFchevron_right

Significance of p53, pRb and Ki-67 markers in Cervical intraepithelial lesion and Malignancy

Biomedical Research and Therapy, 2015

View PDFchevron_right

Human papillomavirus DNA and virus-encoded antigens in cervical carcinoma

The Medical journal of Malaysia, 1997

View PDFchevron_right

Viral and cellular biomarkers used for improving prevention and management of cervical cancer

ANA-CATALINA SAVU

Practica medicală, 2021

View PDFchevron_right

Diagnostic and Prognostic Use of DNA Image Cytometry In Cervical Squamous Intraepithelial Lesions and Invasive Carcinoma

Cancer Cytopathology, 2004

View PDFchevron_right